Selenoprotein N: an endoplasmic reticulum glycoprotein with an early developmental expression pattern

Area of Science:

• Molecular Biology
• Genetics
• Biochemistry

Background:

• SEPN1 gene mutations cause rigid spine muscular dystrophy and multiminicore disease, forming SEPN1-related myopathy.
• The function of selenoprotein N (SEPN1), encoded by the SEPN1 gene, remains largely unknown.
• Previous studies suggested two SEPN1 isoforms based on transcript analysis.

Purpose of the Study:

• To characterize the main protein product of the SEPN1 gene.
• To determine the subcellular localization and post-translational modifications of SEPN1.
• To investigate the expression pattern of SEPN1 in human tissues and cell types.

Main Methods:

• Utilized polyclonal antibodies against SEPN1 and cDNA constructs for isoform analysis.
• Performed subcellular fractionation and endoglycosidase H sensitivity assays.
• Conducted immunofluorescence microscopy and green fluorescent protein (GFP) fusion experiments.

Main Results:

• Identified a 70 kDa glycoprotein as the primary SEPN1 gene product, containing a single selenocysteine residue.
• Demonstrated SEPN1 localization within the endoplasmic reticulum, with an N-terminal targeting and retention signal.
• Observed high SEPN1 expression in fetal tissues and lower levels in adult tissues, including skeletal muscle.

Conclusions:

• SEPN1 is a selenoprotein localized to the endoplasmic reticulum, likely playing a role in cellular processes.
• Expression patterns suggest SEPN1 involvement in early development, cell proliferation, or muscle regeneration.
• Further research into SEPN1 function is warranted for understanding SEPN1-related myopathies.